Freely accessible large language models for parent education in pediatric immune thrombocytopenia: an expert-rated cross-sectional study of safety, readability, and guideline concordance - Scorecard - MDSpire
Advertisement
Freely accessible large language models for parent education in pediatric immune thrombocytopenia: an expert-rated cross-sectional study of safety, readability, and guideline concordance
Clinical Scorecard: Evaluation of Open-Access Large Language Models for Educating Parents on Pediatric Immune Thrombocytopenia: A Cross-Sectional Study of Safety, Readability, and Compliance with Clinical Guidelines
At a Glance
Category
Detail
Condition
Pediatric Immune Thrombocytopenia (ITP)
Key Mechanisms
Acquired immune-mediated bleeding disorder characterized by isolated thrombocytopenia.
Target Population
Parents of children diagnosed with ITP.
Care Setting
Parent-facing health education.
Key Highlights
Freely accessible LLMs can produce supportive parent-facing explanations about childhood ITP.
Gemini 3 Flash achieved the highest mean composite score for communication performance.
Two instances of unsafe content were detected in Gemini 3 Flash responses.
Medical accuracy and guideline concordance were largely similar across models.
Guideline-Based Recommendations
Diagnosis
ITP is diagnosed when isolated thrombocytopenia is present without an alternative cause.
Management
Outpatient management is suggested for children with newly diagnosed ITP and no or mild bleeding.
Monitoring & Follow-up
Follow-up should be reliable, focusing on bleeding severity and quality of life rather than platelet count alone.
Risks
Life-threatening bleeding, including intracranial hemorrhage, is rare but possible.
Patient & Prescribing Data
Children with immune thrombocytopenia.
Most children recover within months, with remission depending on various factors.
Clinical Best Practices
Ensure AI-generated information supports appropriate triage and avoids unnecessary treatment expectations.
Educate families on the relationship between platelet count and bleeding risk.
